Technology

AddToAny

Google+ Facebook Twitter Twitter

Sebia enters agreement

The test mitigates the potential interference in visualisation of M-proteins in immunofixation electrophoresis caused by DARZALEX. 

bio

DARZALEX is a human monoclonal antibody targeting CD38 that provides superior clinical benefit to monotherapy in heavily pre-treated multiple myeloma (MM) patients and when combined with standard of care regimens for the treatment of MM. 
sebia.com

Related Articles

HOW WELL DO CANCER DRUGS HIT THEIR TARGETS?

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets in the body.

“CANCEROUS CELLS WORK TOGETHER TO INFILTRATE THE BRAIN”

Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.

MAGNETS ISOLATE CIRCULATING TUMOUR CELLS

Scientists claim that magnets could be used in the body to detect tumour cells that other diagnostic techniques might miss.

my ibms Microscopic of koilocyte cell criteria of hpv human papilloma virus infection pap smear shutterstock

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

Top